Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence

Drug and Alcohol Dependence
Steven ShoptawWalter Ling

Abstract

Methamphetamine dependence and associated medical and psychiatric concerns are significant public health issues. This project evaluated the efficacy of sertraline (50mg bid) and contingency management (CM) for the treatment of methamphetamine dependence. In this randomized, placebo-controlled, double-blind trial, participants completed a 2-week non-medication baseline and were randomized to one of four conditions for 12 weeks: sertraline plus CM (n=61), sertraline-only (n=59), matching placebo plus CM (n=54), or matching placebo-only (n=55). All participants attended clinic thrice-weekly for data collection, medication dispensing, and relapse prevention groups. Outcomes included methamphetamine use (urine drug screening and self-reported days of use), retention (length of stay), drug craving (visual analogue scale), and mood symptoms (Beck Depression Inventory). No statistically significant main or interaction effects for sertraline or CM in reducing methamphetamine use were observed using a generalized estimating equation (GEE), although post hoc analyses showed the sertraline-only condition had significantly poorer retention than other conditions (chi(2) (3)=8.40, p<0.05). Sertraline conditions produced significantly more adv...Continue Reading

References

Jun 1, 1980·Pharmacology, Biochemistry, and Behavior·W H LynessK E Moore
Dec 1, 1994·Journal of Studies on Alcohol. Supplement·R L StoutF K Del Boca
Jun 18, 2003·Journal of Substance Abuse Treatment·Margaret CretzmeyerJames A Hall
Mar 12, 2004·Annual Review of Psychology·T D Wickens
May 14, 2004·Addiction·Richard A RawsonUNKNOWN Methamphetamine Treatment Project Corporate Authors
Jul 3, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Yih-Ing HserDouglas M Anglin
Sep 17, 2004·The American Journal on Addictions·Thomas F NewtonWalter Ling
Mar 2, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Thomas L PattersonSteffanie A Strathdee
Mar 2, 2005·Journal of Urban Health : Bulletin of the New York Academy of Medicine·James A PeckSteven Shoptaw
Aug 2, 2005·The American Journal of Psychiatry·Kathleen M Carroll, Lisa S Onken

❮ Previous
Next ❯

Citations

Oct 9, 2008·Psychopharmacology·Stephen J KishJunchao Tong
Aug 24, 2010·Journal of the International Neuropsychological Society : JINS·Mariana ChernerUNKNOWN HNRC Group
May 11, 2010·Journal of American College Health : J of ACH·Jeremiah Weinstock
Dec 2, 2008·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Ahmed ElkashefJari Tiihonen
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David VlahovSteffanie A Strathdee
Jun 1, 2009·Journal of Addiction Medicine·Charles W MeredithAndrew J Saxon
Jun 19, 2008·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Stephen J Kish
Sep 14, 2007·CNS Drugs·Kevin P Hill, Mehmet Sofuoglu
Jan 20, 2009·The American Journal of Drug and Alcohol Abuse·Martin C McElhineyEdward V Nunes
Oct 13, 2015·Journal of Dual Diagnosis·Tracy L HellemPerry F Renshaw
Jul 24, 2010·Lancet·Grant ColfaxCarl Hart
Nov 18, 2009·Pharmacology & Therapeutics·Bianca Jupp, Andrew J Lawrence
Jan 21, 2009·Drug and Alcohol Dependence·Catherine G SutcliffeDavid D Celentano
Jul 22, 2008·Behavioural Brain Research·Bríd A Nic Dhonnchadha, Kathryn A Cunningham
Oct 16, 2015·Journal of Clinical Psychopharmacology·Mehrdad SalehiMohammad Reza Sharbafchi
Apr 27, 2013·Drug and Alcohol Review·Matthew BrensilverSteven Shoptaw
Jun 23, 2010·British Journal of Clinical Pharmacology·Laurent KarilaSteven L Batki
Oct 27, 2015·International Journal of High Risk Behaviors & Addiction·Maryam BagheriKourosh Kabir
Apr 12, 2015·Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology·Ardita AlikoArjan Vissink
Jan 16, 2015·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Farzin RezaeiShahin Akhondzadeh
Jul 26, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Hassan SolhiAkram Rasti Barzaki
Jan 12, 2016·Fundamental & Clinical Pharmacology·Farzin RezaeiKambiz Hassanzadeh
Dec 9, 2016·Expert Review of Clinical Pharmacology·Javier BallesterMehmet Sofuoglu
Nov 19, 2011·Journal of Pharmacy Practice·Todd BrackinsJulie C Kissack
Nov 2, 2019·Expert Opinion on Pharmacotherapy·Edna Soares, Frederico C Pereira
Dec 22, 2019·Drug and Alcohol Review·Chukwuemeka N OkaforSteve Shoptaw
Dec 2, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Thomas F NewtonRoberta Kahn
Jun 18, 2009·Current Opinion in HIV and AIDS·Hong Van Tieu, Beryl A Koblin
Sep 2, 2020·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Sören Kuitunen-PaulYulia Golub
Sep 4, 2019·Journal of Addictions Nursing·Susanne A Fogger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.